Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review

Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review

Abstract Introduction Combination use of atogepant and onabotulinumtoxinA has the potential to be more effective than either alone for the preventive treatment of chronic migraine (CM) due to their complementary mechanisms of action. This analysis collected real-world data to evaluate the safety, to...

Full description

Bibliographic Details
Main Authors: Andrew M. Blumenfeld, Laszlo Mechtler, Lisa Cook, Christopher Rhyne, Brian Jenkins, Olivia Hughes, Brett Dabruzzo, Aubrey Manack Adams, Merle Diamond
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-09-01
Series:Pain and Therapy
Subjects:
Atogepant
Chronic migraine
Combination treatment
Gepant
OnabotulinumtoxinA
Online Access:https://doi.org/10.1007/s40122-024-00649-8

Internet

https://doi.org/10.1007/s40122-024-00649-8

Similar Items